TDOC logo

Teladoc Health, Inc. (TDOC)

For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Teladoc Health, Inc. (TDOC) trades at $7.28 with AI Score 49/100 (Weak). Teladoc Health, Inc. is a virtual healthcare services provider, offering a range of solutions for various medical conditions. Market cap: 1292006388, Sector: Healthcare.

Last analyzed: Feb 5, 2026
Teladoc Health, Inc. is a virtual healthcare services provider, offering a range of solutions for various medical conditions. The company operates in the United States and internationally, serving employers, health plans, and individual members.
49/100 AI Score MCap 1B Vol 4M

Teladoc Health, Inc. (TDOC) Healthcare & Pipeline Overview

CEOCharles Divita
Employees4620
HeadquartersPurchase, NY, US
IPO Year2015

Teladoc Health is a leading virtual healthcare provider, offering comprehensive telehealth solutions and chronic condition management services globally. With a focus on innovation and accessibility, Teladoc aims to transform healthcare delivery and improve patient outcomes, positioning itself for long-term growth.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Feb 5, 2026

Investment Thesis

Teladoc Health presents a notable research candidate in the rapidly growing telehealth market. While currently unprofitable with a P/E of -3.72 and a negative profit margin of -8.8%, the company's high gross margin of 69.8% indicates potential for future profitability as it scales. Key value drivers include increasing adoption of telehealth services, expansion of chronic condition management programs, and strategic partnerships with healthcare providers and payers. Growth catalysts include ongoing advancements in telehealth technology and favorable regulatory changes. Investors may want to evaluate the company's high beta of 2.14, indicating higher volatility compared to the market. The company's market capitalization is $0.84B as of 2026-02-05.

Based on FMP financials and quantitative analysis

Key Highlights

  • Market capitalization of $0.84 billion reflects the company's current valuation in the market.
  • Gross margin of 69.8% demonstrates strong pricing power and efficient service delivery.
  • P/E ratio of -3.72 indicates the company is currently unprofitable, but with potential for future earnings growth.
  • Beta of 2.14 suggests higher volatility compared to the market, appealing to investors seeking higher returns.
  • No dividend yield, indicating the company is reinvesting earnings for growth rather than distributing profits to shareholders.

Competitors & Peers

Strengths

  • Established brand recognition in the telehealth market.
  • Comprehensive portfolio of virtual care services.
  • Proprietary technology platform.
  • Large network of providers.

Weaknesses

  • Currently unprofitable.
  • High marketing and sales expenses.
  • Dependence on regulatory approvals and reimbursement policies.
  • High beta indicating volatile stock performance.

Catalysts

  • Upcoming: Expansion of chronic condition management programs.
  • Ongoing: Increasing adoption of telehealth services by employers and health plans.
  • Ongoing: Strategic partnerships with healthcare providers and payers.
  • Ongoing: Advancements in telehealth technology.

Risks

  • Potential: Increasing competition from other telehealth providers.
  • Potential: Evolving regulatory landscape and reimbursement policies.
  • Potential: Cybersecurity risks and data breaches.
  • Ongoing: Economic downturn affecting healthcare spending.
  • Ongoing: Dependence on maintaining a large network of qualified providers.

Growth Opportunities

  • Expansion of Chronic Condition Management Programs: Teladoc Health has a significant opportunity to expand its chronic condition management programs, targeting conditions such as diabetes, hypertension, and heart failure. The market for chronic disease management is substantial, with millions of individuals requiring ongoing care. By leveraging its telehealth platform and data analytics capabilities, Teladoc Health can provide personalized and proactive care, improving patient outcomes and reducing healthcare costs. The timeline for expansion is immediate and ongoing, as the company continues to invest in and enhance its chronic condition management offerings.
  • Strategic Partnerships with Healthcare Providers and Payers: Teladoc Health can drive growth through strategic partnerships with healthcare providers and payers. By integrating its telehealth services into existing healthcare systems and insurance plans, Teladoc Health can reach a wider audience and enhance its market penetration. These partnerships can also facilitate data sharing and collaboration, leading to improved care coordination and outcomes. The timeline for securing and implementing these partnerships is ongoing, with the potential for significant impact over the next 1-3 years.
  • International Expansion: Teladoc Health has the opportunity to expand its services internationally, targeting markets with unmet healthcare needs and growing demand for telehealth solutions. By adapting its platform and services to local regulations and cultural preferences, Teladoc Health can establish a presence in new markets and diversify its revenue streams. The timeline for international expansion is ongoing, with a focus on strategic markets in Europe, Asia, and Latin America.
  • Advancements in Telehealth Technology: Ongoing advancements in telehealth technology, such as remote monitoring devices, artificial intelligence, and virtual reality, present opportunities for Teladoc Health to enhance its services and improve patient engagement. By integrating these technologies into its platform, Teladoc Health can provide more personalized and effective care, driving adoption and customer loyalty. The timeline for integrating these technologies is continuous, as the company invests in research and development and explores new innovations.
  • Mental Health Solutions: Teladoc Health's BetterHelp platform offers significant growth potential in the mental health market. With increasing awareness of mental health issues and growing demand for accessible and affordable mental healthcare, BetterHelp is well-positioned to capture a larger share of the market. By expanding its network of therapists and counselors and enhancing its platform features, BetterHelp can provide convenient and effective mental health support to individuals worldwide. The timeline for growth in this area is immediate and ongoing, driven by increasing demand and expanding service offerings.

Opportunities

  • Expansion into new markets and service lines.
  • Strategic partnerships with healthcare providers and payers.
  • Integration of new technologies, such as AI and remote monitoring.
  • Increasing adoption of telehealth services.

Threats

  • Increasing competition from other telehealth providers.
  • Evolving regulatory landscape.
  • Cybersecurity risks.
  • Economic downturn affecting healthcare spending.

Competitive Advantages

  • Network effect: As more patients and providers join the Teladoc platform, the value of the platform increases for all users.
  • Brand recognition: Teladoc is a well-known and trusted brand in the telehealth market.
  • Technology platform: Teladoc's proprietary technology platform provides a seamless and secure virtual care experience.
  • Data analytics: Teladoc leverages data analytics to improve patient outcomes and personalize care.

About TDOC

Teladoc Health, Inc., incorporated in 2002 and headquartered in Purchase, New York, stands as a global leader in virtual healthcare. Originally known as Teladoc, Inc., the company rebranded to Teladoc Health, Inc. in August 2018 to reflect its expanded services and vision. The company was founded with the mission to make healthcare more accessible and convenient through technology. Teladoc Health provides a comprehensive portfolio of virtual care services, addressing a wide spectrum of medical needs, from non-urgent and episodic care to chronic and complicated conditions. Its services include primary and specialty care telehealth solutions, chronic condition management programs, expert medical services, and mental health solutions. These services are delivered through a proprietary technology platform, enabling convenient and secure access to healthcare professionals. Teladoc Health operates under the Teladoc, Livongo, and BetterHelp brands, each catering to specific segments of the virtual care market. The company serves a diverse clientele, including employers, health plans, hospitals and health systems, insurance and financial services companies, and individual members, both in the United States and internationally.

What They Do

  • Provides virtual medical consultations via phone, video, and mobile app.
  • Offers on-demand access to doctors for non-emergency medical issues.
  • Provides chronic condition management programs for diseases like diabetes and hypertension.
  • Offers expert medical opinions for complex medical cases.
  • Provides mental health services through its BetterHelp platform.
  • Connects patients with specialists for various medical needs.
  • Offers a platform for hospitals and health systems to provide virtual care.

Business Model

  • Subscription fees from employers and health plans for access to Teladoc's services.
  • Per-visit fees from individual members for consultations.
  • Revenue from chronic condition management programs.
  • Fees from hospitals and health systems for using Teladoc's platform.

Industry Context

Teladoc Health operates within the rapidly expanding telehealth market, driven by increasing demand for convenient, accessible, and affordable healthcare solutions. The industry is characterized by technological innovation, evolving regulatory landscapes, and growing acceptance from patients and providers. The telehealth market is projected to experience substantial growth in the coming years, fueled by factors such as aging populations, rising healthcare costs, and advancements in communication technologies. Teladoc Health competes with other telehealth providers, traditional healthcare systems, and emerging digital health companies. Key competitors include companies like AZTA, EVO, IMNM, NVCR, and OMCL, each vying for market share in this dynamic and competitive environment.

Key Customers

  • Employers offering Teladoc as a benefit to their employees.
  • Health plans providing Teladoc as a covered service to their members.
  • Hospitals and health systems using Teladoc's platform to expand their reach.
  • Individual members seeking convenient and affordable healthcare.
  • Insurance and financial services companies
AI Confidence: 73% Updated: Feb 5, 2026

Financials

Chart & Info

Teladoc Health, Inc. (TDOC) stock price: $7.28 (+0.23, +3.34%)

Latest News

Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for TDOC.

Price Targets

Wall Street price target analysis for TDOC.

MoonshotScore

49/100

What does this score mean?

The MoonshotScore rates TDOC's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Latest Teladoc Health, Inc. Analysis

TDOC Healthcare Stock FAQ

What does Teladoc Health, Inc. do?

Teladoc Health, Inc. is a global leader in virtual care, offering a comprehensive range of telehealth services to individuals, employers, and health plans. The company provides on-demand access to doctors, specialists, and mental health professionals through phone, video, and mobile app. Teladoc Health's services include general medical consultations, chronic condition management programs, expert medical opinions, and mental health support. By leveraging its proprietary technology platform and extensive network of providers, Teladoc Health aims to make healthcare more accessible, convenient, and affordable for people around the world.

Is TDOC stock worth researching?

TDOC stock presents a mixed investment picture. While the company operates in a high-growth telehealth market and boasts a strong gross margin of 69.8%, it is currently unprofitable with a negative P/E ratio. The company's growth potential is fueled by increasing adoption of telehealth and expansion of its service offerings. However, investors may want to evaluate the company's high beta of 2.14, indicating higher volatility. A decision to invest in TDOC should be based on an individual's risk tolerance and belief in the long-term growth potential of the telehealth market.

What are the main risks for TDOC?

Teladoc Health faces several key risks. Increasing competition from other telehealth providers could erode market share and pricing power. Evolving regulatory landscape and reimbursement policies could impact the company's revenue and profitability. Cybersecurity risks and data breaches pose a threat to patient privacy and the company's reputation. An economic downturn could reduce healthcare spending and negatively affect Teladoc Health's revenue. Maintaining a large and qualified network of providers is also critical, and any disruption to this network could impact service quality and availability.

What are the key factors to evaluate for TDOC?

Teladoc Health, Inc. (TDOC) currently holds an AI score of 49/100, indicating low score. Key strength: Established brand recognition in the telehealth market.. Primary risk to monitor: Potential: Increasing competition from other telehealth providers.. This is not financial advice.

How frequently does TDOC data refresh on this page?

TDOC prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven TDOC's recent stock price performance?

Recent price movement in Teladoc Health, Inc. (TDOC) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Established brand recognition in the telehealth market.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider TDOC overvalued or undervalued right now?

Determining whether Teladoc Health, Inc. (TDOC) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying TDOC?

Before investing in Teladoc Health, Inc. (TDOC), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .

Data provided for informational purposes only.

Analysis Notes
  • Information is based on available data as of 2026-02-05.
  • Future performance is subject to market conditions and company-specific factors.
Data Sources

Popular Stocks